Related Experiment Videos
Acquired QT Prolongation: Mechanisms and Implications
Fu1, Clemo, Ellenbogen
1Medical College of Virginia, Richmond, Virginia.
Cardiology in Review
|June 1, 1999
Summary
Drug-induced QT prolongation can lead to Torsade de pointes (TdP), a dangerous heart rhythm. Recognizing at-risk patients and understanding drug mechanisms are key to preventing and treating this serious complication.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- QT interval prolongation is a known side effect of various medications.
- Torsade de pointes (TdP) is a specific ventricular arrhythmia linked to prolonged QT intervals and U waves.
- The underlying mechanism involves ventricular myocardial repolarization abnormalities and early afterdepolarizations.
Purpose of the Study:
- To review the causes and mechanisms of drug-induced QT prolongation and TdP.
- To highlight the importance of identifying patients at increased risk for TdP.
- To outline the essential components of TdP diagnosis and management.
Main Methods:
- Literature review of drug-induced QT prolongation and TdP.
- Analysis of mechanisms of proarrhythmia.
- Summary of clinical risk factors and management strategies.
Main Results:
- A wide range of drugs, including antiarrhythmics, phenothiazines, tricyclic antidepressants, antihistamines, antibiotics, antifungals, and antianginals, can cause QT prolongation and TdP.
- Patient risk factors can predispose individuals to this adverse drug reaction.
- Effective management involves prompt diagnosis, drug discontinuation, metabolic correction, heart rate support, and magnesium infusion.
Conclusions:
- Drug-induced QT prolongation and TdP are significant iatrogenic risks.
- Early recognition of at-risk patients and offending agents is crucial for prevention.
- Timely and appropriate treatment is essential to improve patient outcomes and avoid mortality.